Noetic — Full Portfolio

Helus Pharma is a clinical-stage biopharmaceutical company developing small-molecule therapies for psychiatric and CNS conditions such as depression, anxiety, schizophrenia, and bipolar disorder.

BiotechDigital HealthHealthtechMental HealthToronto, CA

ESEric So(Co-Founder, Executive Chairman)inJKJohn Kanakis(Co-Founder)inPGPaul Glavine(Co-Founder and Chief Growth Officer)inGabriel Fahel(Executive Officer)Douglas Drysdale(Executive Officer)Jacqueline Poriadjian(Executive Officer)

Co-investorsAWAwareness VentureBABailey Venture PartnersINInnovating CapitalJLJLSO2O2h Ventures

Apollo Neuro makes a wearable device that delivers gentle vibrations ("SmartVibes") intended to balance the autonomic nervous system, aiming to reduce stress, improve sleep, focus, and recovery.

Digital HealthHardwareHealthtechWellness & FitnessPittsburgh, US

KFKathryn Fantauzzi(Co-founder and CEO)inDDDr. David Rabin MD, PhD(Co-founder; neuroscientist and board-certified psychiatrist)

Board seatSSSa'ad Shah· per SEC Form D

Co-investorsIDID8 InvestmentsPOPortfoliaB B CapitalBABain Capital VenturesNENexus Venture PartnersSESeaX Ventures+2 more

AtaiBeckley develops rapid-acting and durable mental health treatments for patients with difficult-to-treat mental health conditions.

BiotechMedical DevicesMental Health

CAChristian AngermayerCFCosmo Feilding Mellen(Founder)inSRSrinivas Rao

Co-investorsBABailey Venture PartnersFJFJ LabsITIter InvestmentsLELeafy TunnelMAMaiora Rebel VenturesPAPalo Santo VC+4 more

CaaMTech is a pharmaceutical drug discovery company that engineers novel small-molecule psychedelic-inspired therapeutics for mental health treatment through structure-activity optimization and safety screening.

BiotechDeep TechMental Health

Andrew Chadeayne(Founder & CEO)inDWDavis Wuolle(Chief Technology Officer & Chief Marketing Officer)in

Co-investorsKOKortschak Investments L.P.

Damona develops precision neuromedicines aimed at treating cognitive deficits associated with neurodegenerative and psychiatric disorders such as Alzheimer's disease, depression, and schizophrenia.

BiotechDeep TechDigital HealthHealthtechMedical Devices

Co-investorsANAngelini VenturesLULumira VenturesTOToronto Innovation Acceleration Partners

Delix Therapeutics develops third-generation, non-hallucinogenic neuroplastogens for people with neurological conditions, using a discovery platform to identify novel compounds.

BiotechDigital HealthMedical Devices

David Olson(Founder)David Olson Nick Haft(Founder)Nick Haft(Founder)

Co-investorsARArtis VenturesBABailey Venture PartnersCACasa Verde CapitalDODolby Family VenturesGAGaingelsOMOMX Ventures+8 more

Diamond Therapeutics is a preclinical biotechnology company developing drug treatments for psychiatric and neurological disorders, with a focus on the pharmacology and therapeutic use of psychedelic compounds.

BiotechHealthtechMental HealthToronto, CA

JBJudy Blumstock(Chief Executive Officer, Founder, Director)inMichael B. McDonnell(Chief Medical Officer)Grant McCutcheon(Chief Financial Officer)in

Co-investorsJLJLSPAPalo Santo VCNENew Enterprise Associates (NEA)NENextech InvestRARA Capital

Focused on serotonin 2A receptor agonists (psychedelics) by managing psychoactivity.

BiotechNew York, US

Shlomi Raz(Director)Robert M. Hershberg(Director)David Socks(Director)Joanna Grace Natasegara(Director)Mary Frances Vernon(Director)John Bryan Clifton(Director)

Gilgamesh Pharmaceutical develops novel chemical entities for psychiatric disorders using medicinal chemistry and AI-powered translational platforms to design rapid-acting therapies targeting neurobiological mechanisms rather than symptom management.

AI & Machine LearningBiotechDigital HealthHealthtechNew York City, US

JSJonathan Sporn(Founder)inAKAndrew Kruegel(Founder)inDSDalibor Sames(Founder)inAndrew Kruegel, Ph.D.(Executive Officer)Thomas Kevin Murphy, Ph.D.(Executive Officer)JSJONATHAN SPORN(Founder)in

Co-investorsAEAera VCALAlumni VenturesAWAwareness VentureFRFrontera Technology VenturesFRFrontier Path VCGAGaingels+26 more

Merlyn builds AI-based solutions designed for education, aimed at schools and classrooms.

AI & Machine LearningEdTech

Co-investorsWEWestern Technology InvestmentLELearn Capital

MindMed is a biotech company developing psychedelic-based therapeutics, including a proprietary orally disintegrating LSD tablet (DT120) and an R-enantiomer of MDMA (DT402), to treat brain health disorders such as generalized anxiety disorder, major depressive disorder, PTSD, and autism spectrum disorder.

BiotechDigital HealthMental HealthNew York, US

SHStephen Hurst(Executive Officer, Director, Promoter)inScott Freeman(Executive Officer)JRJR Rahn(Director)JAMON ALEXANDER RAHN(Executive Officer, Director)CLCarrie Liao(Executive Officer)inMark R. Sullivan(Executive Officer)in

Co-investorsBABailey Venture PartnersBTBT Growth CapitalDADaft CapitalK2K2 HealthVentures

Definium Therapeutics is a biotech company developing psychedelic-based treatments for brain health disorders, including formulations of LSD and MDMA enantiomers targeting depression, anxiety, PTSD, and autism spectrum disorder.

BiotechDigital HealthMental Health

Co-investorsSESeven Hound Ventures

Operating company addressing mental health and wellness.

People Science runs real-world clinical research for the health and wellness industry, offering a decentralized clinical trial platform (Chloe Clinical) and a real-world data collection tool (Chloe LiveLab) alongside clinical research services.

Digital HealthHealthtechWellness & Fitness

NCNoah Craft(Founder)in

Co-investorsACAcre Venture PartnersFTFTW VenturesLILifeforce CapitalBLBluestein VenturesSUSUPPLY CHANGE CAPITAL

Psych Central is a digital publisher providing informational content on mental health, wellness, and medical topics developed in collaboration with licensed medical professionals.

Digital HealthHealthtechMedia & EntertainmentMental HealthWellness & Fitness

Psygen is a licensed manufacturer of pharmaceutical-grade psychedelic active pharmaceutical ingredients for academic research, clinical trials, and authorized medical use.

BiotechDeep TechHealthtechMedical DevicesMental Health

DMDanny Motyka(Co-Founder & CEO)inPVPeter van der Heyden(Co-Founder & Director)in

Co-investorsITIter InvestmentsEIEight Capital

Sana Health develops an audiovisual device intended to help users improve physical recovery and mental well-being, targeting relief and more restful states of mind.

Digital HealthHealthtechMedical DevicesMental HealthLafayette, US

RHRichard Hanbury(Founder)in

Co-investorsALAlumni VenturesASAsia Africa Investment & Consulting (AAIC)CHCheckmate Capital Group LLCCLClick VenturesESEsplanade VenturesFLFlucas Ventures+12 more

A psychedelics research organization that discovers new psychoactive substances and develops compounds and delivery systems for therapeutic use, continuing the work of Dr.

BiotechDeep TechDigital Health

Tactogen develops patented new chemical entities, including benzofuran-based compositions, and conducts preclinical research and publishes data on these compounds.

BiotechDeep TechHealthtech

MBMatthew Baggott(CEO)in

Co-investorsGAGaingelsLELeafy TunnelPSPsyMed Ventures1010X CapitalPAPalo Santo VCWEWefunder

Terran Biosciences is a biotech platform company developing therapeutics and technologies for neurological and psychiatric diseases, including late-stage drug candidates for schizophrenia, psychedelic and empathogen compounds, and an AI-based neuromelanin MRI analysis platform.

AI & Machine LearningBiotechDigital Health

Sam Clark(Chief Executive Officer)Dustin Tetzl(Chief Business Officer)

Co-investorsMAManta International Consultancy S.A.LPSPsyMed VenturesRERed Beard Ventures

Vessel Health offers at-home urine testing and health monitoring solutions designed to help users track and improve their wellness.

Digital HealthHealthtechWellness & FitnessSan Diego, US

JCJon Carder(Executive Officer, Director)in

BoardJared Stein(Director)

Co-investorsCOCove FundGAGaingelsINInterlock CapitalLILigo Partners LLCMOMoore Venture PartnersWEWestern Technology Investment+1 more

Wake offers medicinal and psychedelic fungi therapy combined with genomics-based integration aimed at supporting human health and personal transformation.

BiotechHealthtechWellness & Fitness

NMNick Murray(Founder)in

Woven Science backs, incubates, and builds companies in the psychedelic and wellness space, operating across drug development, health technology, and plant-medicine product development and distribution.

BiotechMental HealthWellness & FitnessNew York City, US

NVNick von Christierson(CEO & Co-Founder)inGHGiles Hayward(President & Co-Founder)inRHRiwa Harfoush(Chief Strategy Officer)inLSLouis Sagar(Chief Experience Officer)inHSHelen Sartory(Chief Financial Officer)in

Co-investorsANAnya CapitalBABattery VenturesFAFalfurriasIVIVP (Institutional Venture Partners)